Orchid BioSciences, Inc ORCH Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Orchid BioSciences, Inc ORCH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: johnsto1 who wrote (13)	5/31/2000 11:00:00 PM
From: Mike McFarland	Read Replies (1) of 94

<The new SNPstream system, designed to score thousands of SNPs per day, will be targeted at academic and biotechnology laboratories with medium-throughput requirements> ...my guess is that it is not very sexy news, so neither shareprice should be affected by the press release--but it is good to see some level of cooperation--maybe a few of these companies will merge and make it easier on us. Of course Third Wave and PE did not happen, so maybe the biotech correction will leave us in a holding pattern on this subset of genomics companies for awhile. Seems like there are more of these genotyping companies than I can keep track of--but I'm just here to learn a little something and own my little piece of the snipatron;-) If you want to surf, here is a place to start and see some of the players names: healthtech.com epochpharm.com healthtech.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next